Startups

Eyebiotech Limited logo

Eyebiotech Limited

Clinical-stage biotechnology company developing therapies for retinal and other sight-threatening eye diseases; acquired by Merck in 2024.

Team

David GuyerDavid GuyerCo-founder and CEO

Investments